Meeting
2012 ASCO Annual Meeting
Detecting prostate cancer in BRCA1 and BRCA2 mutation carriers: A role for EN2?
Authors
Emma Killick
Institute of Cancer Research, Sutton, United Kingdom
Emma Killick , Richard Morgan , Francesca Launchbury , Nicola E. Annels , Elizabeth Bancroft , Elizabeth Page , Elena Castro , Zsofia Kote-Jarai , Ros A. Eeles , Hardev S. Pandha
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer
Track
Genitourinary Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 4653)
DOI
10.1200/jco.2012.30.15_suppl.4653
Abstract #
4653
Poster Bd #
11D
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers to detect clinically significant disease: Results from the initial screening round of the IMPACT study.
First Author: Christos Mikropoulos
Poster
2011 ASCO Annual Meeting
Correlation of germ-line BRCA2 mutations with aggressive prostate cancer and outcome.
First Author: E. Castro
Poster
2024 ASCO Genitourinary Cancers Symposium
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.
First Author: Ekamjit Singh Deol
Poster
2024 ASCO Genitourinary Cancers Symposium
Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy.
First Author: Vittorio Fasulo